1. Home
  2. WLY vs MANE Comparison

WLY vs MANE Comparison

Compare WLY & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Wiley & Sons Inc.

WLY

John Wiley & Sons Inc.

HOLD

Current Price

$38.24

Market Cap

2.0B

ML Signal

HOLD

MANE

Veradermics Incorporated Common Stock

N/A

Current Price

$56.84

Market Cap

1.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WLY
MANE
Founded
1807
2019
Country
United States
United States
Employees
5200
N/A
Industry
Books
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WLY
MANE
Price
$38.24
$56.84
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$78.33
AVG Volume (30 Days)
452.7K
415.5K
Earning Date
03-05-2026
03-30-2026
Dividend Yield
3.69%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.04
N/A
Revenue Next Year
$2.36
N/A
P/E Ratio
$15.84
N/A
Revenue Growth
N/A
N/A
52 Week Low
$28.38
$36.26
52 Week High
$45.60
$69.41

Technical Indicators

Market Signals
Indicator
WLY
MANE
Relative Strength Index (RSI) 67.10 51.54
Support Level $36.11 $54.77
Resistance Level $38.58 $63.03
Average True Range (ATR) 0.94 5.79
MACD -0.07 -0.78
Stochastic Oscillator 69.43 18.24

Price Performance

Historical Comparison
WLY
MANE

About WLY John Wiley & Sons Inc.

John Wiley & Sons Inc is a publisher and a trusted leader in research and learning. The company segment includes: Research, which includes the reporting lines of Research Publishing and Research Solutions, and Learning includes the Academic and Professional reporting lines and consists of publishing, courseware, and assessments. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.

About MANE Veradermics Incorporated Common Stock

Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.

Share on Social Networks: